Preclinical Evaluation of Promitil, a Radiation-Responsive Liposomal Formulation of a Mitomycin C Prodrug, for Use in Chemoradiation Therapy
International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.058
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Elsevier BV